Total Payments
$19,284
2024 Payments
$1,665
Companies
50
Transactions
1,071
Medicare Patients
12,611
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$18,639 (96.7%)
Education$645.15 (3.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,639 | 1,050 | 96.7% |
| Education | $645.15 | 21 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $4,790 | 327 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,957 | 100 | $0 (2024) |
| Amgen Inc. | $1,710 | 89 | $0 (2024) |
| PFIZER INC. | $1,043 | 58 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,017 | 45 | $0 (2023) |
| Amarin Pharma Inc. | $1,015 | 57 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $854.55 | 63 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $833.02 | 48 | $0 (2024) |
| Astellas Pharma US Inc | $716.05 | 17 | $0 (2022) |
| Gilead Sciences, Inc. | $582.58 | 29 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,665 | 64 | ABIOMED ($193.71) |
| 2023 | $1,949 | 105 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($393.37) |
| 2022 | $2,421 | 137 | Janssen Pharmaceuticals, Inc ($558.56) |
| 2021 | $2,379 | 145 | Janssen Pharmaceuticals, Inc ($837.65) |
| 2020 | $2,377 | 135 | Janssen Pharmaceuticals, Inc ($865.53) |
| 2019 | $2,639 | 161 | Janssen Pharmaceuticals, Inc ($873.61) |
| 2018 | $2,852 | 154 | Janssen Pharmaceuticals, Inc ($471.16) |
| 2017 | $3,002 | 170 | Janssen Pharmaceuticals, Inc ($773.29) |
All Payment Transactions
1,071 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $27.26 | General |
| Category: Cardiology | ||||||
| 12/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: DIABETES | ||||||
| 12/10/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: DIABETES | ||||||
| 11/21/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Genetic Disease | ||||||
| 11/02/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Endocrinology | ||||||
| 10/28/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: CARDIOLOGY | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.21 | General |
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $25.58 | General |
| Category: Cardiovascular | ||||||
| 10/16/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Genetic Disease | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: CARDIOLOGY | ||||||
| 09/20/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Cardiology | ||||||
| 09/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/05/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $17.32 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/04/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/30/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Cardiology | ||||||
| 08/27/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $139.31 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/02/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/26/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Cardiology | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.42 | General |
| 07/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.02 | General |
| Category: Cardiovascular | ||||||
| 07/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.05 | General |
| Category: Cardiovascular | ||||||
| 07/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Cardiology | ||||||
| 07/09/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.42 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 3,041 | 4,519 | $1.2M | $338,147 |
| 2022 | 24 | 3,078 | 4,556 | $1.2M | $342,435 |
| 2021 | 22 | 3,173 | 4,725 | $1.2M | $350,548 |
| 2020 | 29 | 3,319 | 4,853 | $1.1M | $322,609 |
Total Patients
12,611
Total Services
18,653
Medicare Billing
$1.4M
Procedure Codes
101
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 480 | 796 | $163,180 | $66,858 | 41.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 187 | 187 | $261,800 | $63,580 | 24.3% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 187 | 374 | $87,890 | $33,935 | 38.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 212 | 213 | $223,650 | $32,445 | 14.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 369 | 499 | $62,375 | $28,919 | 46.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 147 | 588 | $73,500 | $25,015 | 34.0% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 29 | 29 | $58,000 | $19,167 | 33.0% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 222 | 232 | $58,000 | $12,803 | 22.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 80 | 80 | $33,360 | $11,567 | 34.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 105 | 105 | $29,955 | $11,387 | 38.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 614 | 940 | $56,425 | $9,052 | 16.0% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 100 | 100 | $25,800 | $5,972 | 23.1% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 23 | 23 | $11,385 | $4,224 | 37.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 56 | $7,168 | $3,483 | 48.6% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 23 | 23 | $9,338 | $3,079 | 33.0% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 26 | 28 | $12,600 | $1,649 | 13.1% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 40 | 40 | $12,000 | $1,178 | 9.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 18 | 18 | $5,400 | $961.02 | 17.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 67 | 88 | $704.00 | $683.18 | 97.0% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 29 | 29 | $2,900 | $577.97 | 19.9% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 23 | 30 | $1,830 | $561.68 | 30.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 15 | 29 | $1,885 | $530.99 | 28.2% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 12 | 12 | $4,200 | $518.13 | 12.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 504 | 818 | $167,690 | $68,454 | 40.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 181 | 182 | $254,800 | $64,881 | 25.5% |
About David Song, MD FACE
David Song, MD FACE is a Interventional Cardiology healthcare provider based in Tucker, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174619100.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Song, MD FACE has received a total of $19,284 in payments from pharmaceutical and medical device companies, with $1,665 received in 2024. These payments were reported across 1,071 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($18,639).
As a Medicare-enrolled provider, Song has provided services to 12,611 Medicare beneficiaries, totaling 18,653 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Tucker, GA
- Active Since 10/05/2006
- Last Updated 02/22/2010
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1174619100
Products in Payments
- XARELTO (Drug) $4,623
- ENTRESTO (Drug) $1,786
- Repatha (Biological) $1,388
- ELIQUIS (Drug) $1,215
- LifeVest (Device) $1,017
- Vascepa (Drug) $1,015
- JARDIANCE (Drug) $485.56
- NEXLETOL (Drug) $449.20
- VERQUVO (Drug) $384.22
- Corlanor (Drug) $318.51
- PRADAXA (Drug) $315.99
- VYNDAQEL (Drug) $255.91
- OPSUMIT (Drug) $237.36
- Ranexa (Drug) $218.05
- BRILINTA (Drug) $211.71
- CHANTIX (Drug) $207.99
- FARXIGA (Drug) $195.14
- Impella (Device) $193.71
- CAMZYOS (Drug) $191.05
- WATCHMAN FLX (Device) $188.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Tucker
Zakaria Almuwaqqat, M.d, M.D
Interventional Cardiology — Payments: $65,743
Interventional Cardiology $65,743
Sandeep Chandra, Md Facc, MD FACC
Interventional Cardiology — Payments: $14,878
Interventional Cardiology $14,878
Mr. Mark Schneider
Interventional Cardiology — Payments: $3,270
Interventional Cardiology $3,270